Smartkarma Daily Briefs

• Jio Financial Services (JIOFIN IN) has launched a robust digital ecosystem with its flagship JioFinance app, enhancing its tech-driven financial service offerings.
• The digital-first strategy minimizes legacy constraints, enabling personalized financial solutions that significantly boost efficiency and competitive advantage.
• This evolution redefines traditional banking, positioning JFSL as a versatile, technology-led powerhouse for sustainable growth in India’s financial sector.

• Li Auto’s (LI) share surged 13% on photos released on its official Weibo of a BEV SUV slated for release in April, two months ahead of our expectation. 
• Based on information released, we dialed up LI’s BEV forecast from 73K to 106K for 2025, contributing 20% of revenue instead of 15%. 
• We raise LI’s TP from US$22 to US$25 but keep at SELL.

• CEO is clearly saying that demand is growing faster than expected and has visibility into 2025-26 revenues (we have a fairly good line of sight of investment in data centers)
• Models are getting better and using up to 100x more computing power (ie chain of thought and reinforcement learning). The AI market is today Consumer, tomorrow Agentic, later on Physical.  
• The stock is not expensive at 30x FY26 EPS and 24x FY27 EPS. Get over it.

• Raffles Medical Group (RFMD SP) reported mixed 2024 result. However, 2H24 revenue increased 15% YoY, operating profit rose 5% YoY, and adjusted PATMI jumped 38% YoY.
• China operation is recovering, with revenue growing 10% YoY to S$65M in 2024. Three general hospitals in China have demonstrated strong potential for growth and have a positive outlook ahead.
• Raffles has revised its dividend policy to pay out at least 50%. The company intends to buy back up to 100M ordinary shares over the next two years.

• This will be another quick idea flag and different from the typical cheapish-catalyst type situations I have often written about.
• This is a superb business that I’ve been monitoring for awhile that just saw some nasty correction.
• I’ve been tweeting incessantly about this business, and shares finally collapsed yesterday despite a relatively good earnings report.

• Dassault Systèmes CEO highlights European automaker struggles and growth readiness in US and Asia in January 2025.
• SK Hynix achieves impressive 70% yield in HBM4 testing, signaling advancements in memory technology.
• China’s tungsten export controls cause market price fluctuations, disrupting global supply chains. Foxconn partners with Sonora in Mexico for innovative smart city project.

• Lynas, a six and a half billion dollar mining company, faced challenges in their half yearly results with higher unit costs and a significant decrease in cash position.
• The company’s cash reserves have diminished by over $200 million, raising concerns about the sustainability of their operations in the current rare earths price environment.
• Expansion projects in Mount Weld and Kalgoorlie are ongoing, with potential impacts on future financial performance and the need for additional financing options.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

• Dassault Systèmes has agreed to acquire Contentserv, a provider of AI-driven product information management platforms, for EUR220m, enhancing Centric’s PLM offerings for consumer goods industries.   
• Centric aims to reach EUR500m in revenue by 2028, with goals of becoming a EUR1bn brand. Contentserv is expected to boost Centric’s revenue by 25%, contributing to its growth plans.  
• We deem the integration of Contentserv into Centric will occur gradually. Additionally, Centric will benefit from 3D Universes, an AI-based environment designed to leverage legacy 3D designs and PLM data.

• Mesoblast Ltd (MSB AU) has announced pricing for Ryoncil in the U.S. in tandem with the economic value of treatment with product availability planned for the current quarter.
• Wholesale acquisition cost of Ryoncil has been set at $194K per infusion. Ryoncil infusion is given twice per week for 4 weeks. This brings the full treatment cost to $1.55M.
• The pricing is strategically determined against the cost of treating a child who dies of SR-aGvHD of $2.5M and calculated total benefits of patient outcomes using Ryoncil of $3.2–4.1M.

• Cognex is a leader in machine vision, providing ruggedized cameras and software for automation in manufacturing and logistics environments
• Cognex’s products fall into four categories: Guide, Gauge, Inspect, and ID
• ID includes Dataman products for reading barcodes and optical character recognition

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.